Nutritional Formulation
RixenQ Forte
Coenzyme Q10, Omega-3 Fatty Acid, L-Arginine, Vitamin E & Chromium Picolinate Tablets
Specialty Formulation
Axopea
Palmitoylethanolamide (PEA), Acetyl-L-Carnitine, Boscurin & Uridine Monophosphate Tablets
A specialty combination product featuring Palmitoylethanolamide (PEA), Acetyl-L-Carnitine, Boscurin and Uridine Monophosphate.
| Product | Axopea |
|---|---|
| Dosage Form | Tablets |
| Pack Presentation | 10 × 1 × 10 Tablets |
| Company | Rixentis Healthcare |
Product Composition
Composition & Strength
Ingredients and strengths for per tablet.
| Ingredient | Strength |
|---|---|
| Palmitoylethanolamide (PEA) | 300 mg |
| Acetyl-L-Carnitine | 250 mg |
| Boscurin | 150 mg |
| Uridine Monophosphate | 25 mg |
Boscurin comprises extracts of Boswellia serrata and Curcuma longa in a 3:1 ratio.
For product availability, professional enquiries and further pack information, speak with the Rixentis Healthcare team.
More From Our Portfolio
Explore Related Products.
Mineral & Nutritional Formulation
Calrixen Forte
Calcium Citrate Malate, Calcitriol, Vitamin K2-7, EPA & DHA, Vitamin B12, Folic Acid, Zinc & Magnesium Tablets
Sleep Support Formulation
RSleep-M
L-Theanine, Melatonin & Magnesium Tablets